Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size to Hit Around USD 2,517 Mn by 2032 New York, March 27, 2023 (GLOBE NEWSWIRE) -- The global alpha-1 antitrypsin deficiency augmentation therapy market size accounted for USD 1,413 million in 2022 and growth is estimated to accelerate...

Alpha-1 Antitrypsin Deficiency (AATD) Augmentation Therapy Market to Reach US$ 1959.8 Mn by 2026, Favoured by Grifols’ Worldwide Promotion for AlfaCare, Says Fortune Business Insights Pune, July 12, 2019 (GLOBE NEWSWIRE) -- The global alpha-1 antitrypsin deficiency (AATD) augmentation therapy market has been boosted by recent FDA approval for Prolastin-C. According to a report...